News
9,332 News Articles
Oct
13
2022
Clairvoyant's Phase 2 Psilocybin Therapy Trial for Alcohol Use Disorder Obtains Regulatory ...
Clairvoyant Therapeutics ("Clairvoyant"), a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of ...
Psilocybin
Oct
13
2022
Study Shows 4 Hours May Be All It Takes For Ketamine To Start Easing Depression
For those who don't respond to therapy or traditional antidepressant medication, more advanced interventions may offer relief. Ketamine is a drug that ...
Ketamine
Oct
13
2022
The Spravato Controversy: A Row Over the Drug's Efficacy Compels a Reassessment of its Approval
Ketamine, its S-enantiomer, is frequently associated with dissociation, disturbances in consciousness, and major changes to personality and mood. It ...
Oct
13
2022
Silo Pharma Stock Higher After Investors Appraise Innovative Treatment For Nerve Pain And ...
... of ketamine, designated as SPC-26, for the treatment of Fibromyalgia. ... evidence of value from its time-released ketamine delivery system.
Oct
13
2022
Silo Pharma initiates pre-IND package for ketamine to treat fibromyalgia
Silo Pharma says it is preparing a pre-IND package and meeting with the FDA for a topical formulation of ketamine to treat fibromyalgia.
Oct
13
2022
Election: 5 Lane County cities may ban psilocybin-related businesses - The Register Guard
A vendor bags psilocybin mushrooms at a pop-up cannabis market on May 24,. A handful of cities in Lane County are giving voters the option to prohibit ...
Oct
13
2022
Love Pharma says subsidiary MicroDoz Therapy's sponsored trial at Johns Hopkins ...
Love Pharma - a person wearing lab gloves handles psilocybin mushrooms ... with a focus on psilocybin as an aid in the treatment of addiction.
Oct
13
2022
Case Series Examines Psilocybin Microdosing for Chronic Neuropathic Pain
The interviews included discussions about their pain history, previous analgesic strategies, patterns of psilocybin use, perceived psilocybin effects, ...
Psilocybin
Oct
13
2022
Local resident will decide whether they want to allow magic mushrooms - The News-Review
Douglas County voters will get to make a decision about magic mushrooms, or psilocybin, on Nov. 8.
Oct
13
2022
Love Pharma - Johns Hopkins University Psilocybin Trial Advances Toward Launch in 2022
The MicroDoz Therapy team is sponsoring a study to evaluate the effectiveness of psilocybin in treating Cannabis Use Disorder in 12 patients ...
Psilocybin
Cannabis
Oct
13
2022
Crook County ballots going out soon, featuring a loaded slate - Pamplin Media Group
Voters will decide on multiple local candidate positions as well as a museum tax levy and psilocybin proposals. CENTRAL OREGONIAN - Ballots will ...
Oct
13
2022
Clinical study will evaluate psilocybin-assisted therapy for - Press Release - Top Wire News
Details and proposed trial schedule: 12 cannabis use disorder patients will be enrolled between December and January to receive psilocybin-assisted ...
Oct
13
2022
Guest Opinion: Veterans support access to psilocybin therapy in light of suicide crisis
The FDA recently gave psilocybin “breakthrough therapy” designation for treatment resistant depression because it proved effective where other ...
Oct
13
2022
Field Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic App
(TSX-V: FTHW) (“Field Trip” or the “Company”), the global leader in the development and delivery of psychedelic therapies, is pleased to announce that ...
Oct
13
2022
PSYC's Spotlight Media Highlights Revenue Growth and Other Operational Achievements Met in Q3
Developing the Psychedelic Finder brand and technology represents a ... Money is already flowing back into cannabis and psychedelics stocks, ...
Oct
13
2022
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more.
Oct
13
2022
Palo Santo Closes $50M Psychedelic Therapeutics Investment Fund - Benzinga
Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of ...
Oct
13
2022
Psychedelic Medicine for Eating Disorders: Learning to See the Body As Home
Join Pharmacy Times as we welcome back Reid Robison, MD, Chief Medical Officer at Novamind. Dr. Robison discusses psychedelics as an effective and ...
Oct
13
2022
Mainstream Psychedelics Coverage, Conferences Expanding - Green Market Report
Analysts and investors continue to help expand the psychedelics industry, building their coverage and adding new business conferences.
Psychedelics
Oct
13
2022
Midterms 2022: Middle America Ponders Pot Reform - Investing Daily
Here's an updated, state-by-state round-up of the marijuana initiatives facing voters on November 8. Even psychedelics is on the ballot.
Oct
13
2022
Psychedelic Drugs Market to Receive Overwhelming Growth of USD 6,401.95 Million by ...
Psychedelic drugs involve various types of chemical substances including lysergic acid diethylamide (LSD) and chemical extracted from plants. These ...
Oct
13
2022
Guide For Investors In Psychedelic Companies In Emerging Markets - The Tradable
Because of the increased potential that has lately been connected to psychedelic medications, interested market participants are eager about how ...
Oct
13
2022
New Group Focused on Standardizing Psychedelic Therapy Practices | High Times
The American Psychedelic Practitioners Association, a new group founded to foster professionalism and standards of care in psychedelic therapy, ...
Oct
13
2022
What to Know About Microdosing - Next Avenue
On the other hand, psychedelics are potent 5HT-2A-R receptor agonists; this receptor is found in high concentrations in brain regions vulnerable to ...
Oct
13
2022
Elon Musk advocates the use of MDMA and psychedelic drugs - Cape Town ETC
He is known to carry around a chart at parties explaining the medicinal benefits of psychedelic drugs to anyone willing to listen. In a recent New ...
MDMA
Oct
13
2022
IntelGenx's Collaboration with atai Life Sciences Culminates in the Initiation of First ... - StreetInsider
... Clinical Study of an Oral Thin Film Psychedelic Drug Candidate ... psychedelics based on IntelGenx's polymeric film technologies.
Oct
13
2022
Love Pharma says subsidiary MicroDoz Therapy's sponsored trial at Johns Hopkins ...
... use disorder to be conducted at the Johns Hopkins Center for Psychedelic and Consciousness Research is advancing toward launch later in 2022.
Oct
13
2022
PharmAla appoints Dr. Leah Mayo to Scientific Advisory Board - Yahoo Finance
PharmAla Biotech (CSE: MDMA) is excited to welcome Dr. Leah Mayo to the company's Scientific Advisory Board. Dr. Mayo recently took up the role of ...
Oct
13
2022
Psychedelics Stream: New Platforms And Apps Providing Up-To-Date Info & Resources
The growing acceptance of psychedelics as a source for treating health conditions and promoting wellbeing has led several companies and non-profit ...
Oct
13
2022
Microdoses of Mushrooms against Anxiety Become Trend in Brazil - Folha - UOL
Twenty minutes after taking psilocybin, I feel the anxiety going away, I feel good and happy." Studies point to the potential for reducing symptoms of ...
Oct
13
2022
Can psychedelics combat prolonged grief? Dell Medical School launches study to find out
Researchers will examine brain responses following treatment with psilocybin, a psychedelic derived from certain mushrooms, and 5-MeO-DMT, ...
Oct
13
2022
Soft Reboot Wellness' Ketamine Depression Treatment Now Available for Los Altos
Menlo Park, California--(Newsfile Corp. - October 13, 2022) - Soft Reboot Wellness' recently updated ketamine therapy provides clients with.
Ketamine
Oct
13
2022
Depression, psychiatrists: “A new drug works on the most severe forms”
“Esketamine is a mirror molecule of ketamine, an old anesthetic also used as a hallucinogen that acts in a completely different way from 'classic' ...
Oct
13
2022
PATIENT INFORMATION ON SAFE KETAMINE USE NOW AVAILABLE - Yahoo Finance
The American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) is excited to announce the publication of the Patient ...
Ketamine
Oct
13
2022
Relmada blames placebo for its depression woes - Evaluate Pharma
SLS-002, Seelos Therapeutics, Intranasal racemic ketamine, NCT04669665 completes Dec 2022. Phase 1. AV-101, Vistagen Therapeutics ...
Oct
13
2022
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats - Benzinga
The reason why companies offering psychedelic-assisted therapy only use ketamine is that at the moment it is the only one that holds a medical ...
Ketamine